Evidence map›Paper›PMID 41283036›Full record

ArticleFrontiers in public health2025

Active screening and molecular epidemiological characteristics of fecal colonization by carbapenem-resistant

Hui Zhang, Cong Zhou, Maosuo Xu, Chunmei Shen, Fang Shen, Yong Lin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hui Zhang *Department of Clinical Laboratory, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Cong Zhou *Department of Clinical Laboratory, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Maosuo XuDepartment of Clinical Laboratory, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Chunmei ShenDepartment of Clinical Laboratory, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Fang ShenDepartment of Clinical Laboratory, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Yong LinDepartment of Clinical Laboratory, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Active screening for fecal colonization by carbapenem-resistant Methods: From March 1, 2022 to February 28, 2023, fecal swabs from 435 ICU patients were analyzed using resistant bacteria chromogenic plates. Duplicate strains from the same patient were excluded. Infection prevention and control (IPC) measures were implemented for patients with positive CRE screening results. Bacterial identification, antimicrobial susceptibility testing, multilocus sequence typing (MLST), capsule serotypes, whole-genome sequencing (WGS), and core-genome MLST (cgMLST) were conducted to analyze the molecular epidemiological features and homology of these strains. Results: The prevalence of CRE-FC in ICU wards was 12.6% (55/435). The predominant CRE-FC was Conclusion: CRKP-FC was predominant in CRE-FC. Furthermore, phylogenetic analysis suggested that CRKP-FC had clonal spread in ICU wards, with ST11-KL64 as the main clone. Active CRE-FC screening and IPC interventions can effectively reduced CRE infection rates.

Indexed as

Carbapenem-Resistant EnterobacteriaceaeEnterobacteriaceaeEnterobacteriaceae InfectionsFecesIntensive Care UnitsMass ScreeningAdultAgedCarbapenemsChinaCross InfectionFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedCarbapenemsactive screeningcarbapenem-resistant Enterobacteralesfecal colonizationhomologymolecular epidemiological characteristics

Identifiers

PMID41283036
PMCPMC12635915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.